Search Results - "Vrenken, H"

Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis by Balk, L J, Steenwijk, M D, Tewarie, P, Daams, M, Killestein, J, Wattjes, M P, Vrenken, H, Barkhof, F, Polman, C H, Uitdehaag, B M J, Petzold, A

“…Objective To investigate the coexistence of anterograde and retrograde trans-synaptic axonal degeneration, and to explore the relationship between selective…”
Get full text

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis by Granziera, Cristina, Wuerfel, Jens, Barkhof, Frederik, Calabrese, Massimiliano, De Stefano, Nicola, Enzinger, Christian, Evangelou, Nikos, Filippi, Massimo, Geurts, Jeroen J G, Reich, Daniel S, Rocca, Maria A, Ropele, Stefan, Rovira, Àlex, Sati, Pascal, Toosy, Ahmed T, Vrenken, Hugo, Gandini Wheeler-Kingshott, Claudia A M, Kappos, Ludwig

“…Quantitative MRI provides biophysical measures of the microstructural integrity of the CNS, which can be compared across CNS regions, patients, and centres. In…”
Get full text

Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis by Popescu, V., Battaglini, M., Hoogstrate, W.S., Verfaillie, S.C.J., Sluimer, I.C., van Schijndel, R.A., van Dijk, B.W., Cover, K.S., Knol, D.L., Jenkinson, M., Barkhof, F., de Stefano, N., Vrenken, H.

“…Brain atrophy studies often use FSL-BET (Brain Extraction Tool) as the first step of image processing. Default BET does not always give satisfactory results on…”
Get full text

Mind the gap: from neurons to networks to outcomes in multiple sclerosis by Chard, Declan T., Alahmadi, Adnan A. S., Audoin, Bertrand, Charalambous, Thalis, Enzinger, Christian, Hulst, Hanneke E., Rocca, Maria A., Rovira, Àlex, Sastre-Garriga, Jaume, Schoonheim, Menno M., Tijms, Betty, Tur, Carmen, Gandini Wheeler-Kingshott, Claudia A. M., Wink, Alle Meije, Ciccarelli, Olga, Barkhof, Frederik

“…MRI studies have provided valuable insights into the structure and function of neural networks, particularly in health and in classical neurodegenerative…”
Get full text

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults by Cortese, Rosa, Battaglini, Marco, Prados, Ferran, Bianchi, Alessia, Haider, Lukas, Jacob, Anu, Palace, Jacqueline, Messina, Silvia, Paul, Friedemann, Wuerfel, Jens, Marignier, Romain, Durand-Dubief, Françoise, de Medeiros Rimkus, Carolina, Callegaro, Dagoberto, Sato, Douglas Kazutoshi, Filippi, Massimo, Rocca, Maria Assunta, Cacciaguerra, Laura, Rovira, Alex, Sastre-Garriga, Jaume, Arrambide, Georgina, Liu, Yaou, Duan, Yunyun, Gasperini, Claudio, Tortorella, Carla, Ruggieri, Serena, Amato, Maria Pia, Ulivelli, Monica, Groppa, Sergiu, Grothe, Matthias, Llufriu, Sara, Sepulveda, Maria, Lukas, Carsten, Bellenberg, Barbara, Schneider, Ruth, Sowa, Piotr, Celius, Elisabeth G, Proebstel, Anne-Katrin, Yaldizli, Özgür, Müller, Jannis, Stankoff, Bruno, Bodini, Benedetta, Carmisciano, Luca, Sormani, Maria Pia, Barkhof, Frederik, De Stefano, Nicola, Ciccarelli, Olga

“…Abstract MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating…”
Get full text

Predicting clinical progression in multiple sclerosis after 6 and 12 years by Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., Schoonheim, M. M.

“…Background and purpose To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. Methods…”
Get full text

Amnestic Mild Cognitive Impairment: Structural MR Imaging Findings Predictive of Conversion to Alzheimer Disease by Karas, G, Sluimer, J, Goekoop, R, van der Flier, W, Rombouts, S.A.R.B, Vrenken, H, Scheltens, P, Fox, N, Barkhof, F

“…Mild cognitive impairment (MCI) is considered by many to be a prodromal phase of Alzheimer disease (AD). We used voxel-based morphometry (VBM) to find out…”
Get full text

Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis by Lazzarotto, Andrea, Hamzaoui, Mariem, Tonietto, Matteo, Dubessy, Anne-Laure, Khalil, Michael, Pirpamer, Lukas, Ropele, Stefan, Enzinger, Christian, Battaglini, Marco, Stromillo, Maria Laura, De Stefano, Nicola, Filippi, Massimo, Rocca, Maria Assunta, Gallo, Paolo, Gasperini, Claudio, Stankoff, Bruno, Bodini, Benedetta

“…Cortical myelin loss and repair in multiple sclerosis (MS) have been explored in neuropathological studies, but the impact of these processes on…”
Get full text

Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR by Noteboom, Samantha, van Nederpelt, D. R., Bajrami, A., Moraal, B., Caan, M. W. A., Barkhof, F., Calabrese, M., Vrenken, H., Strijbis, E. M. M., Steenwijk, M. D., Schoonheim, M. M.

“…Background and objectives Disability and cognitive impairment are known to be related to brain atrophy in multiple sclerosis (MS), but 3D-T1 imaging required…”
Get full text

Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset by Meijerman, A, Amiri, H, Steenwijk, M D, Jonker, M A, van Schijndel, R A, Cover, K S, Vrenken, H

“…Precise in vivo measurement of deep GM volume change is a highly demanded prerequisite for an adequate evaluation of disease progression and new treatments…”
Get full text

Regional DTI differences in multiple sclerosis patients by Roosendaal, S.D., Geurts, J.J.G., Vrenken, H., Hulst, H.E., Cover, K.S., Castelijns, J.A., Pouwels, P.J.W., Barkhof, F.

“…Diffusion tensor imaging (DTI) measures have shown to be sensitive to white matter (WM) damage in multiple sclerosis (MS), not only inside focal lesions but…”
Get full text

Hippocampal atrophy rates in Alzheimer disease : Added value over whole brain volume measures by HENNEMAN, W. J. P, SLUIMER, J. D, BARNES, J, VAN DER FLIER, W. M, SLUIMER, I. C, FOX, N. C, SCHELTENS, P, VRENKEN, H, BARKHOF, F

“…To investigate the added value of hippocampal atrophy rates over whole brain volume measurements on MRI in patients with Alzheimer disease (AD), patients with…”
Get full text

Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods by de Sitter, A., Visser, M., Brouwer, I., Cover, K. S., van Schijndel, R. A., Eijgelaar, R. S., Müller, D. M. J., Ropele, S., Kappos, L., Rovira, Á., Filippi, M., Enzinger, C., Frederiksen, J., Ciccarelli, O., Guttmann, C. R. G., Wattjes, M. P., Witte, M. G., de Witt Hamer, P. C., Barkhof, F., Vrenken, H.

“…Background Recent studies have created awareness that facial features can be reconstructed from high-resolution MRI. Therefore, data sharing in neuroimaging…”
Get full text

What drives MRI-measured cortical atrophy in multiple sclerosis? by Popescu, V, Klaver, R, Voorn, P, Galis-de Graaf, Y, Knol, DL, Twisk, JWR, Versteeg, A, Schenk, GJ, Van der Valk, P, Barkhof, F, De Vries, HE, Vrenken, H, Geurts, JJG

“…Background: Cortical atrophy, assessed with magnetic resonance imaging (MRI), is an important outcome measure in multiple sclerosis (MS) studies. However, the…”
Get full text

Comparing lesion segmentation methods in multiple sclerosis: Input from one manually delineated subject is sufficient for accurate lesion segmentation by Weeda, M.M., Brouwer, I., de Vos, M.L., de Vries, M.S., Barkhof, F., Pouwels, P.J.W., Vrenken, H.

“…•Lesion segmentation is an important tool in multiple sclerosis (MS) research.•Several automated methods exist, e.g., supervised, trained or deep…”
Get full text

Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis by Weeda, Merlin M., van Nederpelt, D. R., Twisk, J. W. R., Brouwer, I., Kuijer, J. P. A., van Dam, M., Hulst, H. E., Killestein, J., Barkhof, F., Vrenken, H., Pouwels, P. J. W.

“…Background Multiple sclerosis (MS) is characterized by pathology in white matter (WM) and atrophy of grey matter (GM), but it remains unclear how these…”
Get full text

Accumulation of cortical lesions in MS: relation with cognitive impairment by Roosendaal, SD, Moraal, B, Pouwels, PJW, Vrenken, H, Castelijns, JA, Barkhof, F, Geurts, JJG

“…Background Gray matter (GM) lesions are frequently found in multiple sclerosis (MS) and their in-vivo detection has been improved using new magnetic resonance…”
Get full text

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis by Vrenken, H., Jenkinson, M., Horsfield, M. A., Battaglini, M., van Schijndel, R. A., Rostrup, E., Geurts, J. J. G., Fisher, E., Zijdenbos, A., Ashburner, J., Miller, D. H., Filippi, M., Fazekas, F., Rovaris, M., Rovira, A., Barkhof, F., de Stefano, N.

“…Focal lesions and brain atrophy are the most extensively studied aspects of multiple sclerosis (MS), but the image acquisition and analysis techniques used can…”
Get full text

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a by Vrenken, H., Battaglini, M., de Vos, M. L., Nagtegaal, G. J., Teixeira, B. C. A., Seitzinger, A., Jack, D., Sormani, M. P., Uitdehaag, B. M. J., Versteeg, A., Comi, G., Kappos, L., De Stefano, N., Barkhof, F.

“…Objective Evaluate the effect of subcutaneous interferon β-1a (sc IFN β-1a) versus placebo on the evolution of T1-weighted MRI lesions and central brain…”
Get full text

White Matter Hyperintensity Volume and Cerebral Perfusion in Older Individuals with Hypertension Using Arterial Spin-Labeling by van Dalen, J W, Mutsaerts, H J M M, Nederveen, A J, Vrenken, H, Steenwijk, M D, Caan, M W A, Majoie, C B L M, van Gool, W A, Richard, E

“…White matter hyperintensities of presumed vascular origin in elderly patients with hypertension may be part of a general cerebral perfusion deficit, involving…”
Get full text